Patents by Inventor Kevin Wei

Kevin Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100330098
    Abstract: The present disclosure describes an unexpected and novel insight into hepatic insulin resistance through the description of the ability of VEGF inhibitors to revert hyperglycemia and hyperinsulimenia in murine Type 2 diabetes mellitus models through modulation of a HIF-2?-IRS-2 axis operative in hepatocytes. As such, the data of the present disclosure uncover a novel pathway regulating hepatic IRS-2 expression, and identify VEGF inhibitors as an FDA-approved class of therapeutics capable of increasing liver IRS levels and ameliorating Type 2 diabetes mellitus. Accordingly, this disclosure identifies stabilization of HIF-2? as a robust method for improving glucose metabolism.
    Type: Application
    Filed: June 29, 2010
    Publication date: December 30, 2010
    Inventors: Calvin J. Kuo, Kevin Wei
  • Patent number: 6730036
    Abstract: Ultrasonic imaging to receive a signal from contrast agent microbubbles in arterioles of a myocardium, without being masked by a signal from microbubbles in capillaries of the myocardium. For example, high power ultrasonic energy is emitted to destroy microbubbles in the arterioles and capillaries. A time delay passes from the destruction. The time delay is sufficiently long to allow the arterioles to refill with microbubbles and sufficiently short so that the capillaries do not completely refill with microbubbles. Ultrasonic imaging is then performed to receive a signal between harmonics from the microbubbles refilled in the arterioles. Various other destructive and non-destructive imaging techniques are disclosed.
    Type: Grant
    Filed: February 28, 2002
    Date of Patent: May 4, 2004
    Assignees: Koninklijke Philips Electronics, N.V., University of Virginia
    Inventors: Patrick G. Rafter, Jerome F. Witt, Sanjiv Kaul, Kevin Wei, George A. Brock-Fisher
  • Publication number: 20030163048
    Abstract: Ultrasonic imaging to receive a signal from contrast agent microbubbles in arterioles of a myocardium, without being masked by a signal from microbubbles in capillaries of the myocardium. For example, high power ultrasonic energy is emitted to destroy microbubbles in the arterioles and capillaries. A time delay passes from the destruction. The time delay is sufficiently long to allow the arterioles to refill with microbubbles and sufficiently short so that the capillaries do not completely refill with microbubbles. Ultrasonic imaging is then performed to receive a signal between harmonics from the microbubbles refilled in the arterioles. Various other destructive and non-destructive imaging techniques are disclosed.
    Type: Application
    Filed: February 28, 2002
    Publication date: August 28, 2003
    Inventors: Patrick G. Rafter, Jerome F. Witt, Sanjiv Kaul, Kevin Wei, George A. Brock-Fisher
  • Patent number: D839122
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: January 29, 2019
    Assignee: Michael Kors, L.L.C.
    Inventors: Antonin Ghirardi, Kevin Wei